Yan Fu

RECOMBINANT HUMAN SERUM ALBUMIN-COLLAGEN BINDING DOMAIN FUSION PROTEIN FOR TUMOR-SPECIFIC TARGETING MATRIX, AND USE THEREOF

TEMPERATURE SENSITIVE GEL DAMAGE REPAIR FORMULATION AND APPLICATION THEREOF

Fusion Protein of Human Serum Albumin and Interleukin-2, and Use Thereof

USE OF HUMAN SERUM ALBUMIN IN TREATMENT OF DISEASES

YOUNG AND UNDAMAGED HUMAN SERUM ALBUMIN IMPROVES LONGEVITY OF HUMAN

DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE

FEDERATED LEARNING FOR IMPROVING MATCHING EFFICIENCY

Image clustering method and apparatus, and storage medium

MULTI-MODEL TRAINING BASED ON FEATURE EXTRACTION

METHOD, ELECTRONIC DEVICE AND STORAGE MEDIUM FOR ITEM RECOMMENDATION

MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF

METHOD FOR INHIBITING LYMPHANGIOGENESIS BY ADMINISTRATION OF AN INHIBITOR OF THE CXCL12 PATHWAY

DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE

TUMOR BIOMARKER

Method of inhibiting or treating cancer metastasis

ENDOSTATIN MUTANTS WITH MUTATIONS AT ATP BINDING SITES

Methods and compositions for enhancing the uptake of therapeutic agents by target cells

Endostatin mutants with mutations at ATP binding sites

METHOD AND MEDICAMENT FOR INHIBITING LYMPHANGIOGENESIS

METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AGENTS BY TARGET CELLS

Application of fibrinogen-420 and its active domain

CONJUGATE ANGIOSTATION OR ITS FRAGMENT, THE METHOD OF PRODUCING THE CONJUGATE AND USE THEREOF

Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy

Method for cancer detection

USE OF NUCLEOLIN AS A BIOMARKER FOR LYMPHANGIOGENESIS IN CANCER PROGNOSIS AND THERAPY

NOVEL APPLICATION OF FIBRINOGEN-420 AND ITS ACTIVE DOMAIN

Tumor biomarker

CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR PRODUCING THE CONJUGATE AND USE THEREOF